EPISODE · Jul 4, 2026 · 19 MIN
Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast
from The Deep Dive: Where Elite Builders Share the Secrets Behind Their Success
Novo Nordisk is investing $4.1 billion in a 1.4-million-square-foot, 10-building manufacturing expansion in Clayton, North Carolina to ramp Ozempic and Wegovy production — and BE&K Building Group just landed the build as Design-Builder and Agency Construction Manager across a 56-acre campus. We break down why life-sciences construction is the new megaproject gold rush, how the design-build delivery model changes who wins subcontracts, and how mid-market contractors can position for phased 2027-2
NOW PLAYING
Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m